Gene therapy and Bio marker for Diabetes

Biomarkers are useful tools for research into type 1 diabetes (T1D) for a number of purposes, including elucidation of disease pathogenesis, risk prediction, and therapeutic monitoring. Susceptibility genes and islet autoantibodies are currently the most useful biomarkers for T1D risk prediction, progress, opportunities, challenges, and future directions in the development of T1D biomarkers.

 

    Related Conference of Gene therapy and Bio marker for Diabetes

    September 09-10, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    September 09-10, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    September 09-10, 2024

    4th European Endocrinology and Diabetes Congress

    Paris, France
    September 25-26, 2024

    5th World Summit on Diabetes Expo

    Rome, Italy
    October 14-15, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands

    Gene therapy and Bio marker for Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in